The risk of depression in the menopausal stages: A systematic review and meta-analysis Author links open overlay panelYasmeen Badawy, Aimee Spector, Zishi Lee, Roopal Desai

https://www.sciencedirect.com/science/article/pii/S0165032724006438?via%3Dihub&utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_Jbww5vBokX67H2MdtD0z3mm2iVVcWozps4kD0VZerdDbgnvx_MPZWnUaB6hAaMGbRD1JqkslBg7YjUL1fzKUa4eeXSg&_hsmi=305080140&utm_content=305080140&utm_source=hs_email Entering menopause can increase the risk of depression For people with ovaries, the transition into menopause comes with a 40% higher risk of both experiencing depressive symptoms and getting diagnosed with depression than those who are premenopausal, according to a study published Tuesday in the Journal of Affective Disorders. But the increase isn’t permanent — researchers found no difference in risk between people who were pre- and postmenopausal. Researchers analyzed data from previous studies to assess the risk of depression associated with each stage of menopause, capturing more than 11,000 people. Their highest risk occurred during the years of perimenopause, when a person’s ovaries begin to stop working, fewer hormones are produced, and periods become irregular. The results indicate a need for early depression screening and treatment for women in midlife, the authors write, as well as more research on the mechanisms that increase risk. However, other scientists argue that the recent surge in health services and new medications geared toward menopause frame the experience too much like a disease, and call for more non-medical approaches to manage symptoms. Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition Annalisa Merelli By Annalisa Merelli Jan. 10, 2024v https://www.statnews.com/2024/01/10/menopause-treatment-bayer-elinzanetant-hot-flash-relief/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9fSjk-8wbVRV8WYZR4Gh2UmC0zW-_u1EFopqbkZgypnAw9kOnO9R6MTkiRb3B_r_5rQv-ZbooeXA69DWUYyRNvaOVsfw&_hsmi=305080140&utm_content=305080140&utm_source=hs_email How telehealth startups are trying to fill the menopause care vacuum Katie Palmer By Katie Palmer July 17, 2023 https://www.statnews.com/2023/07/17/menopause-treatment-hrt-telehealth/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9h37a8x4836ht47kkZZwk-eg57fsncY8vAQ6IlyQQ_4EKwXECtlJ7zPZBNxuDjfBNCQbzJLKqkc64GEi04DvatiImq3w&_hsmi=305080140&utm_content=305080140&utm_source=hs_email It’s time to stop treating menopause like a disease, researchers argue in series of Lancet articles Annalisa Merelli By Annalisa Merelli March 5, 2024 https://www.statnews.com/2024/03/05/lancet-menopause-symptoms-new-approach-menopause-medication/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9_g_362muhkhd0giMGPBMYRO5qT-ib6UGheGYP8P_F2syie5ojVWYaDQ2ShIT2gV0VFV7HiniFblBeUbDL8j16R_iqrQ&_hsmi=305080140&utm_content=305080140&utm_source=hs_email